New York, Sept. 24, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030” – https://www.reportlinker.com/p06151667/?utm_source=GNW

The global checkpoint inhibitors market is expected to grow from $15.29 billion in 2020 to $18.04 billion in 2021 at a compound annual growth rate (CAGR) of 18%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $39.81 billion in 2025 at a CAGR of 22%.

The checkpoint inhibitors market consists of sales of the immune checkpoint inhibitor drugs and related services by entities (organizations,…

Read more…

Share.

Comments are closed.